Attorney Profiles
Attorney at Law, Patent Attorney
Kaoru Kuroda
Partner
Main Areas of Practice

Kaoru Kuroda is a partner in Abe, Ikubo and Katayama, where her practice focuses on providing the highest quality results for foreign corporations in patent litigation and other intellectual property matters.  In particular, Kaoru has significant experience representing clients in patent litigation involving major entities in the pharmaceutical, chemical, electronic, semiconductor and telecommunication industries.  Kaoru has demonstrated an ability to present a myriad of complex technologies in simple and understandable terms both in writing and in oral argument.

 

Kaoru received a Master of Science in chemistry from Kyoto University.  Before admitted to the Japanese Bar in 2007, she had dealt with patent prosecutions and invalidation trials in the fields of organic compounds, pharmaceuticals, machines, electronic materials, business methods and others for eight years.  Kaoru served as a judicial intern for Chief Judge Rader at the U.S. Court of Appeals for the Federal Circuit in 2011–2012.  After admitted to the New York Bar in 2012, she worked at Kirkland & Ellis LLP as a visiting attorney for six months.

 

Kaoru frequently speaks about diverse issues of patent law and other intellectual property matters at conferences and seminars both in Japanese and English.  Kaoru has also participated in legal education by lecturing at the Japan Patent Office, Tokyo University, Kobe University and other organizations.

 

Kaoru has taken an active role as a member of Patent System Subcommittee and Design System Subcommittee of the Intellectual Property Committee under the Japanese Government Industrial Structure Council in which to discuss revision of the Patent Act and the Design Act.

Education
  • B.S., Chemistry, Faculty of Science, Kyoto University (1996)
  • M.S., Chemistry, Graduate School of Sciences, Kyoto University (1998)
  • J.D., Keio Law School (2006)
  • LL.M., University of Virginia School of Law (2011)
Admissions
  • Attorney-at-Law (Japan and New York)
  • Patent Attorney (Japan)
Publications and Articles
  • “Study on Requirements for Claiming Damages Based on Lost Profits” AIPPI International Edition Vo.38 No.4, July 2013 (Co-author)
  • “Indirect Infringement of Patent for Combination of Drugs” AIPPI International Edition Vo.38 No.3, May 2013
  • “Efforts To Establish Clear Standards For Exhaustion In Japan” Washington Journal of Law, Technology & Arts, Volume 7, Issue 4 Spring 2012 (Co-author)
Lectures / Presentations
  • Presentation “Reconsideration of IP Dispute Resolution System in Japan – Introducing a New Evidence Collection Procedure” AIPLA Mid-Winter Institute (Tampa), Jan. 30, 2019.
  • Panelist “Global Litigation, Intellectual Property Symposium” held by DLA Piper (Tokyo), Nov. 29, 2018.
  • Played a role of attorney for implementer side “Mock International Arbitration -Toward Early Dispute Resolution of Standard Essential Patents (SEPs) in the 5G Era–” held by the Japan Patent Office (Tokyo), 29, 2018.
  • Presentation “Cases of Clarity Requirement of PBP Claims after the Supreme Court Decision” AIPLA Mid-Winter Institute (Fort Lauderdale), Feb. 1, 2017.
  • Panelist “United States/Japan Patent Symposium” at the United States Court of Appeals for the Federal Circuit (Washington, DC), May 13, 2016.
  • Panelist “Paying the Piper: Fee Shifting in IP Litigation outside the U.S.” AIPLA Mid-Winter Institute (La Quinta), Jan. 30, 2016.
  • Presentation “How different or similar? – Japanese litigation in Asian countries” AIPLA Mid-Winter Institute (La Quinta), Jan. 26, 2016.
  • Presentation “Recent Decision(s) Relating to Employee Inventions” AIPLA Mid-Winter Institute (Orlando), Jan. 27, 2015.
  • Presentation “Patent Exhaustion in Japan” AIPLA Mid-Winter Institute (Phoenix), Jan. 28, 2014.
  • Presentation “Indirect Infringement of Patent for Combination of Drugs (part 2)” AIPLA, AIPPI and Japan Federation of Bar Associations Joint-Meeting (Tokyo), Apr. 10, 2013.
  • Presentation “Indirect Infringement of Patent for Combination of Drugs” AIPLA Mid-Winter Institute (Tampa), Jan. 29, 2013.